콘텐츠로 건너뛰기
Merck
  • Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.

Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.

Internal medicine (Tokyo, Japan) (2012-09-20)
Yukari Fujita, Daisuke Tamada, Junji Kozawa, Yoko Kobayashi, Shugo Sasaki, Tetsuhiro Kitamura, Tetsuyuki Yasuda, Norikazu Maeda, Michio Otsuki, Kohei Okita, Hiromi Iwahashi, Hideaki Kaneto, Tohru Funahashi, Akihisa Imagawa, Iichiro Shimomura
초록

We herein describe a 59-year-old woman who had undergone a total gastrectomy for gastric carcinoma and suffered from postprandial hypoglycemia characterized by a loss of consciousness and spasms. She was diagnosed with reactive hypoglycemia and treated with nutrition therapy, but the frequency and severity of the hypoglycemic episodes did not decrease. She was subsequently treated successfully with miglitol, an alpha-glucosidase inhibitor (α-GI) taken twice a day; other α-GIs (acarbose and voglibose) were not effective. In conclusion, the administration of miglitol was effective for preventing reactive hypoglycemia secondary to late dumping syndrome.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
1-Deoxynojirimycin hydrochloride
Sigma-Aldrich
Miglitol